Wed, Sep 17, 2014, 7:48 AM EDT - U.S. Markets open in 1 hr 42 mins

Recent

% | $
Quotes you view appear here for quick access.

Arena Pharmaceuticals, Inc. Message Board

  • faosto faosto Jan 2, 2013 10:13 PM Flag

    Feurst4ein is doubling down on his 2012 bad call

    In 2012 he said ARNA's Belviq would not get approved - for the second time. It was approved, with two no's versus VIVUS' four. Now he's saying this as one of his 2013 predictions.:
    1. The U.S. commercial launch of Arena Pharmaceuticals(ARNA_) and Eisai's weight-loss pill Belviq will be a major disappointment. Belviq will also fail to receive European approval.

    I think the EU will approve it for its safety profile, and for it's novel mechanism of action. The EU rejecte4d Qsymia. And contrary to VIVUS' dissappointing entry into the field, I think Esai's will be a success.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Why would you even waste your time on that #$%$ He is a paid fraud. He was out of a job when he took the job to write for those crooks. He lies about everything and usually cannot remember what he has written and often steps on his own tongue. Don't bother giving him the time of day. Eventually you will see him hand cuffed getting into a Cop car being lead off to prison for mis-representing which is a FEDERAL OFFENSE.

      Sentiment: Hold

 
ARNA
3.92+0.01(+0.26%)Sep 16 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.